Mycoplasma pneumoniae (MP) is one of the main causes of both upper and lower respiratory infections in school-aged children, accounting for up to 40% of community-acquired pneumonia. Younger children are also affected, and extrapulmonary manifestations have been recently reported in the pediatric population. We carried out a retrospective analysis of MP-positive patients admitted to the Pediatric Emergency Unit of S. Orsola Malpighi University Hospital in Bologna, the largest tertiary pediatric referral center in the Emilia–Romagna region, Northern Italy, between 2012 and 2020. We identified 145 patients with MP infection (82 males and 63 females), 27% of which were younger than 2 years; the median age was 5 years (interquartile range 1–9). The clinical presentation partially differed between age groups. School-aged children were more likely to have a chest X-ray-confirmed pneumonia (p = 0.013), while younger children required oxygen therapy more often (p = 0.048). Seventy-four children (51%) showed extrapulmonary manifestations, mainly gastrointestinal (30%) and dermatological (14%). Neurological symptoms were more frequent in children older than 6 years (p = 0.006). The rate of other extrapulmonary manifestations did not differ significantly between age groups. This study shows that MP infection is a frequent cause of pediatric hospitalization, including of children younger than 2 years. Clinicians should be aware of the variable clinical expressions of MP, including extrapulmonary manifestations, to achieve a correct diagnosis and determine appropriate treatment.

Pulmonary and extrapulmonary manifestations in hospitalized children with mycoplasma pneumoniae infection / Biagi C.; Cavallo A.; Rocca A.; Pierantoni L.; Antonazzo D.; Dondi A.; Gabrielli L.; Lazzarotto T.; Lanari M.. - In: MICROORGANISMS. - ISSN 2076-2607. - ELETTRONICO. - 9:12(2021), pp. 2553.1-2553.14. [10.3390/microorganisms9122553]

Pulmonary and extrapulmonary manifestations in hospitalized children with mycoplasma pneumoniae infection

Biagi C.
Primo
;
Cavallo A.
;
Rocca A.;Pierantoni L.;Antonazzo D.;Dondi A.;Lazzarotto T.;Lanari M.
Ultimo
2021

Abstract

Mycoplasma pneumoniae (MP) is one of the main causes of both upper and lower respiratory infections in school-aged children, accounting for up to 40% of community-acquired pneumonia. Younger children are also affected, and extrapulmonary manifestations have been recently reported in the pediatric population. We carried out a retrospective analysis of MP-positive patients admitted to the Pediatric Emergency Unit of S. Orsola Malpighi University Hospital in Bologna, the largest tertiary pediatric referral center in the Emilia–Romagna region, Northern Italy, between 2012 and 2020. We identified 145 patients with MP infection (82 males and 63 females), 27% of which were younger than 2 years; the median age was 5 years (interquartile range 1–9). The clinical presentation partially differed between age groups. School-aged children were more likely to have a chest X-ray-confirmed pneumonia (p = 0.013), while younger children required oxygen therapy more often (p = 0.048). Seventy-four children (51%) showed extrapulmonary manifestations, mainly gastrointestinal (30%) and dermatological (14%). Neurological symptoms were more frequent in children older than 6 years (p = 0.006). The rate of other extrapulmonary manifestations did not differ significantly between age groups. This study shows that MP infection is a frequent cause of pediatric hospitalization, including of children younger than 2 years. Clinicians should be aware of the variable clinical expressions of MP, including extrapulmonary manifestations, to achieve a correct diagnosis and determine appropriate treatment.
2021
Pulmonary and extrapulmonary manifestations in hospitalized children with mycoplasma pneumoniae infection / Biagi C.; Cavallo A.; Rocca A.; Pierantoni L.; Antonazzo D.; Dondi A.; Gabrielli L.; Lazzarotto T.; Lanari M.. - In: MICROORGANISMS. - ISSN 2076-2607. - ELETTRONICO. - 9:12(2021), pp. 2553.1-2553.14. [10.3390/microorganisms9122553]
Biagi C.; Cavallo A.; Rocca A.; Pierantoni L.; Antonazzo D.; Dondi A.; Gabrielli L.; Lazzarotto T.; Lanari M.
File in questo prodotto:
File Dimensione Formato  
microorganisms-09-02553.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 979.97 kB
Formato Adobe PDF
979.97 kB Adobe PDF Visualizza/Apri
microorganisms-09-02553-s001.zip

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Altra tipologia di licenza compatibile con Open Access
Dimensione 144.58 kB
Formato Zip File
144.58 kB Zip File Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/851775
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact